| Oct 16 |
Scilex gains on spinoff plans for pharma subsidiary
|
| Oct 16 |
Scilex Holding Company Announces that its Board of Directors has Authorized Management to Explore Ways to Maximize the Value of its Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., including by way of conducting a spinoff or public listing of secu...
|
| Oct 16 |
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semn...
|
| Oct 7 |
Scilex Holding Starts $50 Million Registered Direct Offering of Convertible Notes
|
| Oct 7 |
Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile
|
| Sep 26 |
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025
|
| Sep 12 |
Scilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)
|
| Sep 12 |
Private companies account for 46% of Scilex Holding Company's (NASDAQ:SCLX) ownership, while institutions account for 22%
|
| Sep 10 |
Top 3 Health Care Stocks That Could Blast Off In September
|
| Sep 5 |
Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024
|
